RVTY · News · 20260809N

Revenue Performance and Mix

REVVITY, INC. · 2026-08-09 · Importance 37 · Surprise 32

Revvity reported strong second-quarter results and exceeded expectations on August 8, 2026. Pro forma organic revenue grew 3% year over year, exceeding the $21 million materiality threshold implied by the company’s $711 million revenue benchmark. Diagnostics made a significant contribution, while improving Life Sciences order activity reflected increased demand from pharmaceutical and biotech customers, including AI-driven drug discovery tools.

Key facts

• Revvity saw pro forma organic revenue growth of 3% in the second quarter. source
• Revvity reported adjusted earnings per share of $1.41 for the second quarter. source
• Revvity’s CFO said the Diagnostics segment made significant contributions to results. source